|
US20040171062A1
(en)
|
2002-02-28 |
2004-09-02 |
Plexxikon, Inc. |
Methods for the design of molecular scaffolds and ligands
|
|
AU2003272548A1
(en)
|
2002-09-16 |
2004-04-30 |
Plexxikon, Inc. |
Crystal structure of pim-1 kinase
|
|
US20050048573A1
(en)
|
2003-02-03 |
2005-03-03 |
Plexxikon, Inc. |
PDE5A crystal structure and uses
|
|
JP2007524374A
(ja)
|
2003-02-28 |
2007-08-30 |
プレキシコン，インコーポレーテッド |
Ｐｙｋ２結晶構造および使用
|
|
US20050079548A1
(en)
|
2003-07-07 |
2005-04-14 |
Plexxikon, Inc. |
Ligand development using PDE4B crystal structures
|
|
US7348338B2
(en)
|
2003-07-17 |
2008-03-25 |
Plexxikon, Inc. |
PPAR active compounds
|
|
CA2532403A1
(en)
|
2003-07-17 |
2005-02-03 |
James Arnold |
Ppar active compounds
|
|
WO2005028624A2
(en)
|
2003-09-15 |
2005-03-31 |
Plexxikon, Inc. |
Molecular scaffolds for kinase ligand development
|
|
US20070066641A1
(en)
|
2003-12-19 |
2007-03-22 |
Prabha Ibrahim |
Compounds and methods for development of RET modulators
|
|
US7517970B2
(en)
|
2003-12-19 |
2009-04-14 |
Plexxikon, Inc. |
Nucleic acids encoding kinase and phosphatase enzymes, expression vectors and cells containing same
|
|
CN1925855B
(zh)
|
2003-12-19 |
2010-06-16 |
普莱希科公司 |
开发Ret调节剂的化合物和方法
|
|
EP1742627A4
(en)
|
2004-05-06 |
2009-08-26 |
Plexxikon Inc |
PDE4B HEMMER AND ITS USE
|
|
JP2008503473A
(ja)
|
2004-06-17 |
2008-02-07 |
プレキシコン，インコーポレーテッド |
Ｃ−ｋｉｔ活性を調節する化合物
|
|
US7498342B2
(en)
|
2004-06-17 |
2009-03-03 |
Plexxikon, Inc. |
Compounds modulating c-kit activity
|
|
WO2006026754A2
(en)
|
2004-09-03 |
2006-03-09 |
Plexxikon, Inc. |
Bicyclic heteroaryl pde4b inhibitors
|
|
JP2008521829A
(ja)
|
2004-11-30 |
2008-06-26 |
プレキシコン，インコーポレーテッド |
Ｐｐａｒ活性化合物
|
|
JP2008521831A
(ja)
|
2004-11-30 |
2008-06-26 |
プレキシコン，インコーポレーテッド |
Ｐｐａｒ活性化合物
|
|
US20060160135A1
(en)
|
2004-12-08 |
2006-07-20 |
Weiru Wang |
SF-1 and LRH-1 modulator development
|
|
US7846941B2
(en)
|
2005-05-17 |
2010-12-07 |
Plexxikon, Inc. |
Compounds modulating c-kit and c-fms activity and uses therefor
|
|
UA95244C2
(ru)
|
2005-06-22 |
2011-07-25 |
Плексикон, Инк. |
Соединения и способ модулирования активности киназ, и показания для их применения
|
|
WO2007030559A2
(en)
|
2005-09-07 |
2007-03-15 |
Plexxikon, Inc. |
1, 3-disubstituted indole derivatives for use as ppar modulators
|
|
JP2009509932A
(ja)
|
2005-09-07 |
2009-03-12 |
プレキシコン，インコーポレーテッド |
Ｐｐａｒ活性化合物
|
|
BRPI0615948A2
(pt)
|
2005-09-07 |
2011-05-31 |
Plexxikon Inc |
composto ativo de ppar, sua composição, seu kit e seu uso
|
|
WO2008063888A2
(en)
|
2006-11-22 |
2008-05-29 |
Plexxikon, Inc. |
Compounds modulating c-fms and/or c-kit activity and uses therefor
|
|
JP2010514695A
(ja)
|
2006-12-21 |
2010-05-06 |
プレキシコン，インコーポレーテッド |
キナーゼ調節のための化合物および方法およびそのための適応症
|
|
PE20121126A1
(es)
|
2006-12-21 |
2012-08-24 |
Plexxikon Inc |
Compuestos pirrolo [2,3-b] piridinas como moduladores de quinasa
|
|
WO2008079909A1
(en)
|
2006-12-21 |
2008-07-03 |
Plexxikon, Inc. |
Pyrrolo [2,3-b] pyridines as kinase modulators
|
|
EP2121591A2
(en)
|
2007-03-08 |
2009-11-25 |
Plexxikon, Inc. |
Ppar active compounds
|
|
PE20090159A1
(es)
|
2007-03-08 |
2009-02-21 |
Plexxikon Inc |
COMPUESTOS DERIVADOS DE ACIDO INDOL-PROPIONICO COMO MODULADORES PPARs
|
|
WO2009012283A1
(en)
|
2007-07-17 |
2009-01-22 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
WO2009143018A2
(en)
|
2008-05-19 |
2009-11-26 |
Plexxikon, Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
PE20091846A1
(es)
|
2008-05-19 |
2009-12-16 |
Plexxikon Inc |
DERIVADOS DE PIRROLO[2,3-d]-PIRIMIDINA COMO MODULADORES DE CINASAS
|
|
JP5767965B2
(ja)
|
2008-06-10 |
2015-08-26 |
プレキシコン インコーポレーテッドＰｌｅｘｘｉｋｏｎ Ｉｎｃ． |
キナーゼを調節する５ｈ−ピロロ［２，３−ｂ］ピラジン誘導体、およびその適応症
|
|
US8110576B2
(en)
|
2008-06-10 |
2012-02-07 |
Plexxikon Inc. |
Substituted pyrrolo[2,3b]pyrazines and methods for treatment of raf protein kinase-mediated indications
|
|
WO2010104945A1
(en)
|
2009-03-11 |
2010-09-16 |
Plexxikon, Inc. |
Pyrrolo [2, 3-b] pyridine derivatives for the inhibition of raf kinases
|
|
AU2010224184A1
(en)
|
2009-03-11 |
2011-09-29 |
Plexxikon, Inc. |
Pyrrolo [2, 3-b] pyridine derivatives for the inhibition of Raf kinases
|
|
WO2010111527A1
(en)
|
2009-03-26 |
2010-09-30 |
Plexxikon, Inc. |
Pyrazolo [ 3, 4 -b] pyridines as kinase inhibitors and their medical use
|
|
MY172424A
(en)
|
2009-04-03 |
2019-11-25 |
Hoffmann La Roche |
Propane- i-sulfonic acid {3- (4-chloro-phenyl)-1h-pyrrolo [2, 3-b] pyridine-3-carconyl] -2, 4-difluoro-phenyl} -amide compositions and uses thereof
|
|
CA2761009A1
(en)
|
2009-05-04 |
2010-11-11 |
Plexxikon, Inc. |
Compounds and methods for inhibition of renin, and indications therefor
|
|
TW201041888A
(en)
|
2009-05-06 |
2010-12-01 |
Plexxikon Inc |
Compounds and methods for kinase modulation, and indications therefor
|
|
CN106220623A
(zh)
|
2009-11-06 |
2016-12-14 |
普莱希科公司 |
用于激酶调节的化合物和方法及其适应症
|
|
ES2627911T3
(es)
|
2009-11-18 |
2017-08-01 |
Plexxikon, Inc. |
Derivados de N-[2-fluoro-3-(4-amino-7H-pirrolo[2,3-d]pirimidin-5-carbonil)-fenil]-4-bencenosulfonamida como moduladores de la proteína quinasa Raf para el tratamiento del cáncer
|
|
BR112012015745A2
(pt)
|
2009-12-23 |
2016-05-17 |
Plexxikon Inc |
compostos e métodos para a modulação de quinase, e indicações dos mesmos
|
|
TWI510487B
(zh)
|
2010-04-21 |
2015-12-01 |
Plexxikon Inc |
用於激酶調節的化合物和方法及其適應症
|
|
US8642606B2
(en)
|
2010-09-29 |
2014-02-04 |
Plexxikon Inc. |
ZAP-70 active compounds
|
|
US9624213B2
(en)
|
2011-02-07 |
2017-04-18 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
AR085279A1
(es)
|
2011-02-21 |
2013-09-18 |
Plexxikon Inc |
Formas solidas de {3-[5-(4-cloro-fenil)-1h-pirrolo[2,3-b]piridina-3-carbonil]-2,4-difluor-fenil}-amida del acido propano-1-sulfonico
|
|
JP6113151B2
(ja)
|
2011-05-17 |
2017-04-12 |
プレキシコン インコーポレーテッドＰｌｅｘｘｉｋｏｎ Ｉｎｃ． |
キナーゼ調節およびその適応症
|
|
US9358235B2
(en)
|
2012-03-19 |
2016-06-07 |
Plexxikon Inc. |
Kinase modulation, and indications therefor
|
|
US9150570B2
(en)
|
2012-05-31 |
2015-10-06 |
Plexxikon Inc. |
Synthesis of heterocyclic compounds
|
|
EP2892534B8
(en)
|
2012-09-06 |
2021-09-15 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
MX365640B
(es)
|
2012-12-21 |
2019-06-10 |
Plexxikon Inc |
Compuestos y metodos para la modulacion de quinasas y sus indicaciones.
|
|
US20140303121A1
(en)
|
2013-03-15 |
2014-10-09 |
Plexxikon Inc. |
Heterocyclic compounds and uses thereof
|
|
DK2970265T3
(en)
|
2013-03-15 |
2018-10-01 |
Plexxikon Inc |
HETEROCYCLIC COMPOUNDS AND APPLICATIONS THEREOF
|
|
CN105228983A
(zh)
|
2013-05-30 |
2016-01-06 |
普莱希科公司 |
用于激酶调节的化合物及其适应症
|
|
US9771369B2
(en)
|
2014-03-04 |
2017-09-26 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
ES2774177T3
(es)
|
2014-09-15 |
2020-07-17 |
Plexxikon Inc |
Compuestos heterocíclicos y usos de estos
|
|
WO2016164641A1
(en)
|
2015-04-08 |
2016-10-13 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
LT3292123T
(lt)
|
2015-05-06 |
2020-12-28 |
Plexxikon Inc. |
Junginio, moduliuojančio kinazes, kietos formos
|
|
JP6530826B2
(ja)
|
2015-05-06 |
2019-06-12 |
プレキシコン インコーポレーテッドＰｌｅｘｘｉｋｏｎ Ｉｎｃ． |
キナーゼを修飾する１ｈ−ピロロ［２，３−ｂ］ピリジン誘導体の合成
|
|
US9814714B2
(en)
|
2015-05-22 |
2017-11-14 |
Plexxikon Inc. |
Kinase modulation, and indications therefor
|
|
WO2016191295A1
(en)
|
2015-05-22 |
2016-12-01 |
Plexxikon Inc. |
Solid forms of a compound for modulating kinases
|
|
US10829484B2
(en)
|
2015-07-28 |
2020-11-10 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
ES2913048T3
(es)
*
|
2015-09-21 |
2022-05-31 |
Opna Immuno Oncology Sa |
Compuestos heterocíclicos y usos de estos
|
|
MX2018006856A
(es)
|
2015-12-07 |
2018-08-01 |
Plexxikon Inc |
Compuestos y metodos para modulacion de la quinasa, e indicaciones de los mismos.
|
|
ES2904615T3
(es)
|
2016-03-16 |
2022-04-05 |
Plexxikon Inc |
Compuestos y métodos para la modulación de quinasas e indicaciones al respecto
|
|
TW201815766A
(zh)
|
2016-09-22 |
2018-05-01 |
美商普雷辛肯公司 |
用於ｉｄｏ及ｔｄｏ調節之化合物及方法以及其適應症
|
|
EP3558991A2
(en)
|
2016-12-23 |
2019-10-30 |
Plexxikon Inc. |
Compounds and methods for cdk8 modulation and indications therefor
|